India, June 25 -- Today's top gainers in the biotech space include Bio-Techne, following acquisition news; Satellos Bioscience, gearing up to present new DMD data next month; and Kymera, which has revised its clinical data readout timeline, among others.
Read on.
Bio-Techne Acquired by Merck KGaA
Bio-Techne Corp. (TECH) led the pack of gainers on Thursday, with shares soaring over 20%, on acquisition news.
The company has agreed to be acquired by Merck KGaA, Darmstadt, Germany, for US$73 per share in cash, representing a total enterprise value of approximately US$11.3 billion (EUR 9.9 billion), a 36% premium to Bio-Techne's one-month volume weighted average trading price.
Bio-Techne generated net sales of more than US$1.2 billion in fi...